ELVN · Insider Trading

Enliven Therapeutics, Inc. Common Stock

Iron condor setups Expected move IV rank history Fibonacci levels Insider trading

Every open-market purchase and sale reported by ELVN officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.

Form 4 Filings

most recent

Open-Market Buys

code P

Sales

code S

Reporting Insiders

current holders

ELVN — Recent Form 4 Transactions (latest 2026-10-16)

Filed	Insider	Role	Type	Shares	Value
2026-10-16	Kristine M Ball	Director	A	+23,394 deriv.	—
2026-10-05	J. Scott Garland	Director	MIXED	—	−$405.61K
2026-09-21	Helen Louise Collins	CHIEF MEDICAL OFFICER	MIXED	—	−$239.35K
2026-09-21	Benjamin Hohl	CHIEF FINANCIAL OFFICER	MIXED	−2,036	−$243.87K
2026-08-19	Benjamin Hohl	CHIEF FINANCIAL OFFICER	Sell	−6,018	−$352.55K
2026-08-19	Helen Louise Collins	CHIEF MEDICAL OFFICER	MIXED	—	−$280.53K
2026-08-06	Mika K Derynck	Director	MIXED	—	−$7.84M
2026-08-06	Mika K Derynck	Director	MIXED	—	−$7.84M
2026-07-21	Helen Louise Collins	CHIEF MEDICAL OFFICER	MIXED	—	−$250.97K
2026-07-21	Benjamin Hohl	CHIEF FINANCIAL OFFICER	MIXED	−4,946	−$314.12K
2026-07-08	Lori Anne Kunkel	Director	Sell	−10,000	−$504.90K
2026-06-24	ORBIMED ADVISORS LLC	10%+ Owner	Sell	−2,580,369	−$117.04M

ELVN — Current Insider Holders

Insider	Role	Shares Held	Value
ORBIMED ADVISORS LLC	10%+ Owner	220,882	$8.55M
Mika K Derynck	Director	138,304	$5.35M
Lori Anne Kunkel	Director	47,773	$1.85M
Benjamin Hohl	CHIEF FINANCIAL OFFICER	44,018	$1.70M
Helen Louise Collins	CHIEF MEDICAL OFFICER	25,240	$976.79K
J. Scott Garland	Director	13,000	$503.10K

ELVN Insider Trading FAQ

Who are the insiders at ELVN?

6 officers, directors and 10%+ beneficial owners currently report holdings in ELVN via SEC Form 4.

Are ELVN insiders buying or selling?

Across the 12 most recent Form 4 filings for ELVN, 0 were open-market purchases (code P) and 3 were sales (code S). Sales frequently reflect scheduled 10b5-1 plans or tax withholding rather than a view on the stock.

How current is ELVN insider data?

Form 4 must be filed within two business days of the transaction, so this is close to real time. The most recent ELVN filing is dated 2026-10-16.

How to read Form 4 activity

Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.

Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.

Full filing history and per-insider positions are on the ELVN quote page; the site-wide leaderboard is on the insider transactions hub.